
News|Articles|January 26, 2026
AAP publishes 2026 childhood and adolescent immunization schedule
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Celeste Krewson, Assistant Editor, Justin Mancini
The AAP released its 2026 childhood immunization schedule, maintaining evidence-based vaccine recommendations and expanding guidance across routine, catch-up, and risk-based care.
Advertisement
Advertisement
The American Academy of Pediatrics (AAP) has published the Recommended Childhood and Adolescent Immunization Schedule: United States 2026, reaffirming routine immunization to protect infants, children, and adolescents against 18 vaccine-preventable diseases. The schedule continues long-standing AAP guidance for vaccines targeting conditions such as respiratory syncytial virus (RSV), hepatitis A, hepatitis B, rotavirus, influenza, meningococcal disease, measles, and pertussis.1,2
Related to this article

Julie Sweetland, PhD, shares strategies to improve vaccine conversations by explaining the science, acknowledging parental concerns, and building trust.

A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.

New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.

CDC confirmed the first pediatric flu death of 2026-27, linked to H1N1, as early flu activity rises in 2026.

A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.

Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.

The US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.
Advertisement
Advertisement

